Gamma-Linolenic Acid.

Evening primrose oil is one of the two commercial carriers of gamma-linolenic acid, supplying roughly 8 to 10 percent GLA by weight. Listing both means one fatty acid arriving from two places, so the totals add rather than acting separately.

Borage oil is the most concentrated food-grade source of gamma-linolenic acid at around 20 to 24 percent. A formula carrying both is stacking the same molecule, which matters for dosing arithmetic.

GLA elongates to dihomo-gamma-linolenic acid, and part of that pool can convert onward to arachidonic acid. EPA competes for the same elongase and cyclooxygenase steps, which is why long-standing practice pairs GLA with EPA rather than giving it alone.

Marine omega-3s and omega-6 GLA draw on the same desaturase, elongase and oxygenase enzymes, so each shifts the membrane fatty acid mix the other produces. Formulators combine them deliberately to hold the omega-6 to omega-3 balance steady.

Delta-6-desaturase, the enzyme upstream of GLA and the one that limits its formation from linoleic acid, depends on zinc. Adequate zinc keeps the endogenous route working alongside the supplied GLA.

Pyridoxine is a described cofactor for delta-6-desaturase activity in the essential fatty acid pathway. It supports the conversion of linoleic acid into gamma-linolenic acid.

GLA carries three double bonds and oxidises readily in the capsule and in the membrane once incorporated. Tocopherol is the standard chain-breaking antioxidant added to keep the oil intact.

Tocopherol terminates the lipid peroxidation chain that polyunsaturated oils start. It is the conventional stabiliser in a GLA-bearing softgel.

DHA and GLA occupy the same membrane phospholipid positions and are handled by overlapping enzymes. Their ratio sets which eicosanoid and docosanoid products a cell can make.

Astaxanthin sits across the lipid bilayer and quenches peroxyl radicals in the same phase where GLA is stored. It adds a second layer of oxidative protection beside tocopherol.

Delta-6 desaturase inserts a double bond into linoleic acid to give gamma-linolenic acid, so linoleic acid is the substrate the body starts from. Supplemental GLA supplies the product of that step directly, which is why it is used where the desaturation step is thought to run slowly. The relationship is a straight precursor to product one. Providing more precursor does not guarantee more product, because the enzyme is the bottleneck.

Delta-6 desaturase operates as part of a microsomal electron transfer system whose activity is tied to magnesium-dependent steps. Low magnesium status is described as one of the conditions under which conversion of linoleic acid to GLA runs less efficiently. This is cofactor-level reasoning rather than a measured supplementation result. It supports the pairing without claiming a magnitude.

Biotin functions as the carboxyl carrier for acetyl-CoA carboxylase, the committed step of fatty acid synthesis that feeds the elongation and desaturation machinery. It is named alongside zinc and pyridoxine in accounts of desaturase support. The link is upstream and general rather than specific to the GLA step. Confidence is set to match that distance.

Ascorbate contributes reducing equivalents to microsomal reactions and is listed among the nutrients affecting desaturase activity. It also protects the polyunsaturated chain from oxidation in aqueous compartments. Both roles are supportive rather than rate setting. The pairing is mechanistic and is described as such.

Alpha-linolenic acid from flaxseed and linoleic acid from omega-6 sources are handled by the same delta-6 desaturase, and the enzyme has a higher affinity for the omega-3 substrate. A large alpha-linolenic acid load therefore reduces flux down the omega-6 branch. Taking GLA directly sidesteps that competition, which is the practical reason the two are often taken together rather than one being chosen over the other. The direction of the interaction is competition at the enzyme.

GLA is elongated to dihomo-gamma-linolenic acid, which competes with arachidonic acid for cyclooxygenase and lipoxygenase access. Which fatty acid dominates that pool shapes which eicosanoid series is produced. Supplemental arachidonic acid shifts the balance in the opposite direction to a GLA dose. Naming the competition is more useful than calling either fatty acid good or bad.

GLA carries three double bonds and oxidises readily once the seed oil is pressed and exposed to air. Rosemary extract is used alongside tocopherols to slow that oxidation in the finished oil. The benefit is to the material in the capsule rather than to the person taking it. It belongs on the formulation side of the ledger.

Lecithin is used to keep seed oils emulsified in liquid and emulsion formats. For GLA it also supplies phosphatidylcholine, the phospholipid class into which the fatty acid is later incorporated in membranes. The formulation role is the well-supported one. The membrane point is background biochemistry, not a claimed effect.

Seed oils are triglycerides and need bile salt emulsification followed by lipase hydrolysis before their fatty acids are absorbed. Where bile delivery is reduced, absorption of any oil-based fatty acid falls. Supplemental bile acids address that step. The point concerns absorption of the oil, not any action of GLA itself.

GLA in borage or evening primrose oil is esterified into triglycerides and must be hydrolysed before uptake. Lipase performs that hydrolysis at the sn-1 and sn-3 positions. Low lipase activity means less free fatty acid available for absorption. This is digestive physiology, not an added effect.